Compound ID | 1210
Synonym(s): JNJ-Q2
Class: Fluoroquinolone
Spectrum of activity: | Gram-positive |
Details of activity: | Active against methicillin-resistant Staphylococcus aureus |
Description: | Broad Spectrum In Vitro Activity of JNJ-Q2, a New Fluoroquinolone. F1-2033. 48th Annu. Intersci. Conf. Antimicrob. Agents Chemother. (ICAAC)-Infect. Dis. Soc. Am. (IDSA) 46th Annu. Meet. American Society for Microbiology and Infectious Diseases Society of America, Washington, DC. By: Foleno, B |
Institute where first reported: | Johnson & Johnson, Melinta Therapeutics Inc. |
Year first mentioned: | 2008 |
Highest developmental phase: | Phase 2 (NCT01128530) |
Development status: | Active |
Chemical structure(s): | |
Canonical SMILES: | COC1=C(C(=CC2=C1N(C=C(C2=O)C(=O)O)C3CC3)F)N4CCC/C(=C(/CN)\F)/C4 |
Isomeric SMILES: | COC1=C2C(=CC(=C1N3CCC/C(=C(/CN)\F)/C3)F)C(=O)C(=CN2C4CC4)C(=O)O |
InChI: | InChI=1S/C21H23F2N3O4/c1-30-20-17-13(19(27)14(21(28)29)10-26(17)12-4-5-12)7-15(22)18(20)25-6-2-3-11(9-25)16(23)8-24/h7,10,12H,2-6,8-9,24H2,1H3,(H,28,29)/b16-11+ |
InChI Key: | VMKVDAAFMQKZJS-LFIBNONCSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/11546234 |
External links: | |
Guide to Pharmacology: | acorafloxacin |